{"schema_version":"secwatch.filing_event.v1","accession":"0000897101-22-000946","form_type":"8-K","ticker":"ELMD","cik":"0001488917","company_name":"Electromed, Inc.","filed_at":"2022-11-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.823899+00:00","generated_at":"2026-06-22T03:23:19.074892+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Electromed Q1 FY2023 revenue up 7% to $10.7M; net income drops to $0.01 EPS","bullets":["Net revenue $10.7M, +7% YoY; net income $81K ($0.01 diluted EPS) vs $439K ($0.05) last year.","Operating income $44K vs $538K a year ago; SG&A up 17.7% due to legal fees and annual sales meeting.","Cash $6.0M, down $2.2M from June 30; repurchased $145K of stock in quarter.","Next-generation 510(k) submitted to FDA; limited market release expected in fiscal Q2 if clearance by mid-Dec."],"urls":{"canonical":"https://secwatch.observer/filing/0000897101-22-000946","json":"https://secwatch.observer/filing/0000897101-22-000946.json","markdown":"https://secwatch.observer/filing/0000897101-22-000946.md","text":"https://secwatch.observer/filing/0000897101-22-000946.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1488917/000089710122000946/0000897101-22-000946-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1488917/000089710122000946/elmd221300_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T03:23:19.074892+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b9163b0021a421941c8c754234bfd6e91c914f60","claim":"Electromed, Inc. reported the three months ended September 30, 2022 results: revenue $10.7 million, net income $81,000, EPS $0.01 per diluted share.","evidence_excerpt":"Net revenue was $10.7 million for the three months ended September 30, 2022, a 7% increase from $10.0 million for the three months ended September 30, 2021 (\"Q1 FY 2022\")","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1488917/000089710122000946/0000897101-22-000946-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three months ended September 30, 2022"},{"label":"Revenue","value":"$10.7 million"},{"label":"Net income","value":"$81,000"},{"label":"EPS","value":"$0.01 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}